Global Statistics Representing Artificial Tears Market Scenario
Artificial tears solution is primarily used to lubricate dry eyes that are caused due to reduced tear production, increased tear evaporation, or imbalance in tear composition. The solution helps in protecting the eyes from injury and ensuring moisture retention. Growing urbanization along with the rising number of desk jobs is boosting the market growth. For instance, the world’s population living in the urban area is projected to increase from 55% in 2018 to 68% in 2050. This is further supported by rising prevalence of dry eye disease coupled with rising demand for lubricant eye drops. As per a study published in the American Journal of Ophthalmology, the annual prevalence of dry eye disease increased from 0.8% to 3.0% from 2005 to 2012.
What Could Emerge as the Market Drivers?
The excessive usage of artificial tears may cause redness, inflammation, and eye pain, which might limit the use of artificial tears. However, the development of preservative-free tear solutions is expected to mitigate the risks of side effects, thereby, changing the market dynamics over the forecast period.
Cellulose Derived Artificial Tears: Most Prescribed
Global artificial tears market is segmented by type, delivery method, and application. By type, the market is segmented into cellulose derived tears, glycerin derived tears, oil-based emulsion tears, polyethylene glycol, and propylene glycol-based tears. Currently, the cellulose derived tears are dominating the market by generating a huge amount of revenue. From the last few decades, carboxymethyl cellulose has remained to be the most used cellulose derived artificial tear solution. As per a study involving 484 artificial tears prescriptions, 256 were prescribed for carboxymethyl cellulose, and 186 were for hydoxypropyl cellulose.
Glycerin Derived Artificial Tears to Boost the Market Growth
Glycerin derived tears segment is expected to grow at the fastest CAGR in the years to come. This can be attributed to their ability to retain eye moisture for a longer period. In addition to this, the product is cheaper than other types, which is further driving demand for the product. Oasis Tears (Oasis Medical Inc), Refresh Optive and Refresh Optive Advanced (Allergan), and Tears Naturale Forte (Alcon) are some of the readily sold glycerin-based artificial tears.
Eye Drops: First-Line Treatment of Dry Eyes
By the delivery method, the artificial tears market is segmented into eye drops and ointments. In 2018, eye drops remains the leading revenue-generating segment in the market, owing to its commercial availability in the form of eye drops. The product is considered as the mainstream treatment and the first line of therapy for dry eye syndrome. Furthermore, it reduces the need for ointment based artificial tears.
Looking at the side effects of the product, the consumers are preferring the products that are free from preservatives. In line with this, manufacturers have started investing in R&D to develop eye drops free from preservatives.
Millennials Leading the Demand for Artificial Tears
Based on the application, the global artificial tears market is segmented into dry eye treatment and contact lenses moisture. The contact lens moisture segment is projected to grow at the fastest CAGR during the forecast period on account of its increasing adoption across the globe. As per our analysis, more than 125 million people use contact lenses globally. The eye care industry is extensively targeting the millennials as they are the major adopters of contact lenses. However, the demand for single-use contact lenses is also rising in the developed economies, which may have some impact on market growth.
Geographic Landscape: Who is Leading the Market?
Geographically, the global artificial tears market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa (LMEA).
Americas is likely to dominate the global artificial tears market. This can be attributed to the high adoption of treatment therapies and the presence of a favorable reimbursement framework. Dry eye disease is one of the most prevalent conditions in the U.S. as nearly 30% of the U.S. population suffers from dry eye disease. This is further supported by increasing demand for LASIK and refractive surgeries and high adoption of contact lens. For instance, as per CDC estimates an estimated number of 45 million people wear contact lens in the country, representing high demand for artificial tears. Rising medical tourism in the countries such as Brazil and Mexico is further expected to propel the market growth. Medical tourism in Brazil is expected to grow by 35% in the coming five years. Ophthalmic surgery is one of the attractive sectors for medical tourism in Brazil and Mexico.
Europe is likely to emerge as the second largest artificial tears market globally. This can be attributed to increasing prevalnces of age related ophthalmic disorders and dry eye diseases. As per European Society of Retina Specialists (EURETINA), age-related macular degeneration (AMD) affects nearly 34 million people in European Union, every year. This number is expected to rise by 25% by 2050. Similarly, the prevalence of diabetic eye disease is also high in the region. Nearly, 4 million European people suffer from diabetic eye diseases and about 25% of the diabetic eye disease cases require surgical intervention, which is expected to increase the demand for artificial tears in post-operative care.
Asia Pacific is likely to emerge as the fastest-growing region for artificial tears as a result of increasing demand for contact lenses, rising disposable income, and economic development in countries such as China and India. Rising geriatric population, coupled with increasing incidences of eye-related diseases also represents a significant opportunity for market growth. For instance, the geriatric population in Japan is expected to increase from 27.7% in 2015 to over 40% by 2050. Artificial tears contribute the majority of the revenue to the regional dry eye treatment market.
Visual impairment is one of the major health concerns in Africa. Cataracts, glaucoma, and uncorrected refractive errors are the leading health concerns in Africa. However, the adoption of surgical interventions is significantly low in African countries. The awareness regarding the ophthalmic conditions and treatment therapies is low in both the Middle East and Africa. However, with the changing dynamics in the healthcare sector in the Middle East, this trend is expected to change in the coming years.
The global artificial tears market is highly competitive with the presence of players such as Akron Inc., Allergan plc, Novartis International AG, Johnson & Johnson, Ocusoft Inc., Aura lab Ltd., and Carl Zeiss AG. These market players are adopting various strategies like mergers and acquisitions and new product launches to sustain in the intense competition.
Our Report Covers
Artificial Tears Market Segmentation
By Delivery Method
Frequently Asked Questions (FAQs)